Are metallic stents really safe? A long-term analysis in lung transplant recipients

Gottlieb J., Fuehner T., Dierich M., Wiesner O., Simon A. R., Welte T.

Source: Eur Respir J 2009; 34: 1417-1422
Journal Issue: December

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Abstract

Airway complications affect 20% of all lung transplant recipients. Self-expandable metallic stents (SEMS) are one treatment option but their use in benign airway disorders is controversial. We studies the long-term safety of SEMS in lung transplant recipients. Between January 1998 and February 2008, all lung transplant recipients with SEMS were analysed retrospectively at a single centre. Complications were recorded until September 2008. In 65 (9.2%) out of 706 recipients, 111 (91% noncovered) bronchial SEMS were implanted a median (range) 133 (55-903) days after lung transplantation; follow-up was 777 (7-3.655) days. Clinical improvement was noted in 80% of recipients. The forced expiratory volume in 1 s increased by (mean±SD) 21±33%. Most frequent early complications were migration (3%) and mucus plugging (11%). No procedure-related deaths were noted. Re-stenosis occurred in 34 (52%) out of 65 recipients 85 (7-629) days after insertion. In multivariate analysis, stent insertion before post-operative day 90 was independently associated with an increased risk of re-stenosis (HR 3.29, 95% CI 1.50-7.18; p = 0.003). In 40% of recipients, new bacterial airway colonisation occurred after SEMS insertion. In SEMS patients, 5-yr survival was significantly lower than in the total cohort (60% versus 76%; p = 0.02). Late complications in lung transplant recipients treated with SEMS are frequent. The major problems are re-stenosis and airway colonisation.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gottlieb J., Fuehner T., Dierich M., Wiesner O., Simon A. R., Welte T.. Are metallic stents really safe? A long-term analysis in lung transplant recipients. Eur Respir J 2009; 34: 1417-1422

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
Source: Eur Respir J 2011; 37: 164-172
Year: 2011



Biodegradable airway stents for treatment of airway complications after lung transplantation
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans
Source: Eur Respir J 2004; 23: 384-390
Year: 2004



Protective effect of immunosuppression on granulation tissue formation in metallic airway stents
Source: Annual Congress 2006 - Stents and stunts : what's new in airway desobstruction?
Year: 2006


Metallic stent for airway complications after lung transplantation long term follow up
Source: Annual Congress 2013 –Therapeutical bronchoscopy for treatment of airway disorders: laser, stents and more
Year: 2013


Anti-reflux surgery for gastroesophageal reflux disease after lung transplantation: Benefit for lung function, acute rejections and respiratory infections
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015


Is lung transplantation still indicated?
Source: Annual Congress 2006 - Contemporary management of patients with end-stage emphysema
Year: 2006


Evaluation of the bronchial suture in lung transplant recipients with virtual bronchoscopy
Source: Annual Congress 2005 - New modalities and application in lung and airway imaging
Year: 2005


Pathophysiology of the lung allograft: pathways of graft rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005


Non-anastomostic bronchial stenoses after lung transplantation: outcome of endobronchial stent placement
Source: Eur Respir J 2006; 28: Suppl. 50, 723s
Year: 2006

The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx)
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007


Graft versus host disease
Source: Respipedia Article
Year: 2016

Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003



Novel use of paclitaxel-coated balloons in refractory non-anastomotic airway stenosis following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Post-transplant bronchiolitis obliterans
Source: Eur Respir J 2003 Dec 01;22(6):1007-1018
Year: 2003



Noninfectious complications
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=208
Year: 2003

Long-term follow-up of lung transplant recipients with obstructive airway complications
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008



Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004